Quest Diagnostics Incorporated : Driving Sustainable Growth in a Post Pandemic World – Jim Davis

Driving Sustainable

Growth in a Post-

Pandemic World

Jim Davis

Chief Executive Officer and President

SAFE HARBOR DISCLOSURE

The statements in the following presentations which are not historical facts may be forward looking statements. Readers are cautioned not to place undue reliance on forward looking statements, which speak only as of the date that they are made and which reflect management's current estimates, projections, expectations or beliefs and which involve risks and uncertainties that could cause actual results and outcomes to be materially different. Risks and uncertainties that may affect the future results of the company include, but are not limited to, adverse results from pending or future government investigations, lawsuits or private actions, the competitive environment, the complexity of billing, reimbursement and revenue recognition for clinical laboratory testing, changes in government regulations, changing relationships with customers, payers, suppliers or strategic partners and other factors discussed in the company's most recently filed Annual Report on Form 10-K and in any of the company's subsequently filed Quarterly Reports on Form 10-Q and Current Reports on Form 8-K, including those discussed in the "Business," "Risk Factors," "Cautionary Factors that May Affect Future Results" and "Management's Discussion and Analysis of Financial Condition and Results of Operations" sections of those reports.

In the following presentations, references to adjusted EPS refer to adjusted diluted EPS. Any references to base business, testing, revenues, or volumes refer to the performance of our business excluding COVID-19 testing. Any references to operating margin(s) refer to adjusted operating income as a percentage of net revenues. Any references to free cash flow refer to cash flow from operations less capital expenditures.

2

Key highlights

We are poised to grow based on our exceptional capabilities and relationships

We have the right strategy to accelerate growth

Investments in advanced diagnostics and CIT will drive profitable growth

Invigorate will continue to drive operational productivity while improving the customer experience

Long-term outlook 2023-26: Mid single-digit revenue CAGR; and high single-digit adjusted EPS CAGR

3

Introducing The Quest Way with an ambitious Purpose and refreshed Strategy and Culture

PURPOSE

STRATEGY

CULTURE

Working together to create a healthier world, one life at a time

We help people make the best decisions to improve health by providing high-quality and affordable diagnostic testing insights and services using our scale and extensive reach

• Collaborating with payers, providers and partners to leverage our broad access
• Offering the most extensive menu of testing and services
• Leveraging our data assets and services to improve population health and enable value-based care
• Continuously improving our quality and efficiency by embracing AI, automation and other innovation technologies

Who we serve: Patients, Consumers, Physicians, Hospitals, Life Sciences Companies, Employers, Insurers, Retailers, Public Health Agencies and Communities

Customer First, Care, Collaboration, Continuous Improvement, Curiosity

4

We have an established core team and have added experienced leaders focused on profitable growth

Jim	Sam	Cathy	Mark	Patrick	Karthik	Mark
Gardner
Davis	Samad	Doherty	Delaney	Plewman	Kuppusamy
SVP
CEO & President	EVP	SVP	SVP	SVP	SVP	Genomics and Oncology
	Chief Financial Officer	Regional Businesses	Chief Commercial Officer	Diagnostic Services	Clinical Solutions	R&D

Richard	Dermot	Gabrielle	Cecilia	Mike	Gary	Kristin
Adams	Shorten	Wolfson	McKenney	Samuels
Prevoznik	Wallace
VP/GM	SVP	SVP	SVP	SVP
SVP	SVP
Consumer-Initiated	Strategy, M&A and	Chief Information and	Chief Human Resources	Chief Communications
General Counsel	Chief Compliance Officer
Testing	Ventures	Digital Officer	Officer	Officer

5